Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital, Ghent |
---|---|
Information provided by: | University Hospital, Ghent |
ClinicalTrials.gov Identifier: | NCT00228332 |
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
Condition | Intervention | Phase |
---|---|---|
Verrucae Vulgares |
Drug: Administration of zinkgluconaat or placebo |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares |
Estimated Enrollment: | 70 |
Study Start Date: | April 2004 |
Study Completion Date: | March 2006 |
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2004/005 |
Study First Received: | September 13, 2005 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00228332 History of Changes |
Health Authority: | Belgium: Institutional Review Board |
Virus Diseases Skin Diseases, Infectious Warts |
Skin Diseases DNA Virus Infections Papillomavirus Infections |
Skin Diseases, Viral Virus Diseases Skin Diseases, Infectious Neoplasms Warts |
Skin Diseases Tumor Virus Infections DNA Virus Infections Papillomavirus Infections |